Mojirade James - 06 Mar 2023 Form 4 Insider Report for AVANOS MEDICAL, INC. (AVNS)

Role
SVP, General Counsel
Signature
/s/ John Hurley, as attorney-in-fact for Mojirade James
Issuer symbol
AVNS
Transactions as of
06 Mar 2023
Net transactions value
-$62,528
Form type
4
Filing time
07 Mar 2023, 15:51:36 UTC
Previous filing
22 Jul 2022
Next filing
21 Jul 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVNS Common Stock Award $0 +20,339 +76% $0.000000 47,217 06 Mar 2023 Direct F1
transaction AVNS Common Stock Tax liability $62,528 -2,111 -4.5% $29.62 45,106 06 Mar 2023 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents time-based restricted share units awarded pursuant to the Issuer's 2021 Long Term Incentive Plan. The award will vest 1/3 on March 6, 2024, 1/3 on March 6, 2025 and 1/3 on March 6, 2026.
F2 Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of time-based restricted share units awarded to the Reporting Person on March 4, 2022, 1/3 of which vested on March 4, 2023, with the remainder vesting 1/3 on March 4, 2024 and 1/3 on March 4, 2025.